168 related articles for article (PubMed ID: 21508169)
21. A distinct double positive IL-17A
Saini C; Srivastava RK; Kumar P; Ramesh V; Sharma A
Cytokine; 2020 Feb; 126():154873. PubMed ID: 31629113
[TBL] [Abstract][Full Text] [Related]
22. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.
Tanaka S; Nishida Y; Aida K; Maruyama T; Shimada A; Suzuki M; Shimura H; Takizawa S; Takahashi M; Akiyama D; Arai-Yamashita S; Furuya F; Kawaguchi A; Kaneshige M; Katoh R; Endo T; Kobayashi T
Diabetes; 2009 Oct; 58(10):2285-91. PubMed ID: 19641142
[TBL] [Abstract][Full Text] [Related]
23. Autophagy Is an Innate Mechanism Associated with Leprosy Polarization.
Silva BJ; Barbosa MG; Andrade PR; Ferreira H; Nery JA; Côrte-Real S; da Silva GM; Rosa PS; Fabri M; Sarno EN; Pinheiro RO
PLoS Pathog; 2017 Jan; 13(1):e1006103. PubMed ID: 28056107
[TBL] [Abstract][Full Text] [Related]
24. Serum IFN-γ-inducible chemokines CXCL9 and CXCL10 are elevated in non-immediate drug hypersensitivity reactions.
Wang F; Cai R; He D; Zhao Y; Ye Y; Zhang X
Asian Pac J Allergy Immunol; 2016 Sep; 34(3):236-241. PubMed ID: 27001652
[TBL] [Abstract][Full Text] [Related]
25. Expression of interferon-gamma- inducible protein-10 and its receptor CXCR3 in chronic pancreatitis.
Singh L; Bakshi DK; Majumdar S; Vasishta RK; Arora SK; Wig JD
Pancreatology; 2007; 7(5-6):479-90. PubMed ID: 17912012
[TBL] [Abstract][Full Text] [Related]
26. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.
Rao PN; Suneetha S; Pratap DV
Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932
[TBL] [Abstract][Full Text] [Related]
27. Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines.
Rotondi M; Falorni A; De Bellis A; Laureti S; Ferruzzi P; Romagnani P; Buonamano A; Lazzeri E; Crescioli C; Mannelli M; Santeusanio F; Bellastella A; Serio M
J Clin Endocrinol Metab; 2005 Apr; 90(4):2357-63. PubMed ID: 15657375
[TBL] [Abstract][Full Text] [Related]
28. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Shimizu T; Tada Y; Watanabe S
Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000
[TBL] [Abstract][Full Text] [Related]
29. Mast cell heterogeneity and anti-inflammatory annexin A1 expression in leprosy skin lesions.
Costa MB; Mimura KKO; Freitas AA; Hungria EM; Sousa ALOM; Oliani SM; Stefani MMA
Microb Pathog; 2018 May; 118():277-284. PubMed ID: 29605649
[TBL] [Abstract][Full Text] [Related]
30. The exaggerated inflammatory response in Behçet's syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-γ/CXCL10 IP-10 pathway.
Ambrose N; Khan E; Ravindran R; Lightstone L; Abraham S; Botto M; Johns M; Haskard DO
Clin Exp Immunol; 2015 Sep; 181(3):427-33. PubMed ID: 25982097
[TBL] [Abstract][Full Text] [Related]
31. A Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in Ethiopia.
Lambert SM; Alembo DT; Nigusse SD; Yamuah LK; Walker SL; Lockwood DN
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004502. PubMed ID: 27046330
[TBL] [Abstract][Full Text] [Related]
32. Association of viable Mycobacterium leprae with Type 1 reaction in leprosy.
Save MP; Dighe AR; Natrajan M; Shetty VP
Lepr Rev; 2016 Mar; 87(1):78-92. PubMed ID: 27255061
[TBL] [Abstract][Full Text] [Related]
33. Type 1 Reaction in Patients With Leprosy Corresponds to a Decrease in Proresolving Lipid Mediators and an Increase in Proinflammatory Lipid Mediators.
Silva CA; Webb K; Andre BG; Marques MA; Carvalho FM; de Macedo CS; Pinheiro RO; Sarno EN; Pessolani MC; Belisle JT
J Infect Dis; 2017 Feb; 215(3):431-439. PubMed ID: 27932613
[TBL] [Abstract][Full Text] [Related]
34. CXCL10 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Xu Y; Cai S
Mol Biol Rep; 2010 Jul; 37(6):3029-36. PubMed ID: 19821051
[TBL] [Abstract][Full Text] [Related]
35. Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes.
Crescioli C; Cosmi L; Borgogni E; Santarlasci V; Gelmini S; Sottili M; Sarchielli E; Mazzinghi B; Francalanci M; Pezzatini A; Perigli G; Vannelli GB; Annunziato F; Serio M
J Endocrinol; 2007 Oct; 195(1):145-55. PubMed ID: 17911406
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-1β, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis.
Antonelli A; Ferri C; Ferrari SM; De Marco S; Di Domenicantonio A; Centanni M; Pupilli C; Villa E; Menichetti F; Fallahi P
J Interferon Cytokine Res; 2010 Nov; 30(11):835-42. PubMed ID: 20929277
[TBL] [Abstract][Full Text] [Related]
37. Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease.
Han JH; Suh CH; Jung JY; Nam JY; Kwon JE; Yim H; Kim HA
Arthritis Res Ther; 2015 Sep; 17(1):260. PubMed ID: 26385705
[TBL] [Abstract][Full Text] [Related]
38. Association of TNFSF8 regulatory variants with excessive inflammatory responses but not leprosy per se.
Fava VM; Cobat A; Van Thuc N; Latini AC; Stefani MM; Belone AF; Ba NN; Orlova M; Manry J; Mira MT; Thai VH; Abel L; Alcaïs A; Schurr E
J Infect Dis; 2015 Mar; 211(6):968-77. PubMed ID: 25320285
[TBL] [Abstract][Full Text] [Related]
39. CXCL10: a candidate biomarker in transplantation.
Romagnani P; Crescioli C
Clin Chim Acta; 2012 Sep; 413(17-18):1364-73. PubMed ID: 22366165
[TBL] [Abstract][Full Text] [Related]
40. Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions.
Kirkaldy AA; Musonda AC; Khanolkhar-Young S; Suneetha S; Lockwood DN
Clin Exp Immunol; 2003 Dec; 134(3):447-53. PubMed ID: 14632750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
